Opus Genetics, Inc. reports

Company location: Durham, NC
Fiscal year end: 31 December

Opus Genetics, Inc. has filed 1,033 SEC EDGAR filings since 29 Apr 2003

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 601-625 of 839 matching filings.

Per page

25

Current page

25

8-K File 001-34079

8-K

Filing date: 13 Apr 2017
Reporting date: 11 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Apr 2017
Reporting date: 11 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Apr 2017
Reporting date: 11 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Apr 2017
Reporting date: 10 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Apr 2017
Reporting date: 11 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Apr 2017
Reporting date: 11 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Apr 2017
Reporting date: 11 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-34079

REXAHN PHARMACEUTICALS INC. DEF 14A 4-11-2017

Filing date: 24 Feb 2017
Reporting date: 11 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-34079

REXAHN PHARMACEUTICALS 10-K 12-31-2016

Filing date: 24 Feb 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRE 14A File 001-34079

REXAHN PHARMACEUTICALS INC. PRE 14A 4-11-2017

Filing date: 13 Feb 2017
Reporting date: 11 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jan 2017
Reporting date: 20 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jan 2017
Reporting date: 20 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jan 2017
Reporting date: 20 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jan 2017
Reporting date: 20 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jan 2017
Reporting date: 20 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-79996

REXAHN PHARMACEUTICALS, INC.

Filing date: 17 Jan 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-79996

SABBY 13G-A RNN 1.10.17

Filing date: 10 Jan 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 11-22-2016

Filing date: 25 Nov 2016
Reporting date: 22 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 15 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC 10-Q 9-30-2016

Filing date: 04 Nov 2016
Reporting date: 30 Sep 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 14 Oct 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 30 Sep 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-34079

REXAHN PHARMACEUTICALS INC 8-K 9-19-2016

Filing date: 20 Sep 2016
Reporting date: 19 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-196255

REXAHN PHARMACEUTICALS, INC. 424B5 9-14-2016

Filing date: 15 Sep 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-34079

REXAHN PHARMACEUTICALS INC 8-K 9-14-2016

Filing date: 14 Sep 2016
Reporting date: 14 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .